Home LiteratureArticle Details
PMID: 8408653 Published · ppublish English Case Reports Journal Article Research Support, U.S. Gov't, P.H.S.

Defective splicing of mRNA from one COL1A1 allele of type I collagen in nondeforming (type I) osteogenesis imperfecta.

The Journal of clinical investigation ·Vol. 92 ·No. 4 ·1993-10-00 ·Pages 1994-2002

Stover ML, Primorac D, Liu SC, McKinstry MB, Rowe DW

Abstract

Osteogenesis imperfecta (OI) type I is the mildest form of heritable bone fragility resulting from mutations within the COL1A1 gene. We studied fibroblasts established from a child with OI type I and demonstrated underproduction of alpha 1 (I) collagen chains and alpha 1 (I) mRNA. Indirect RNase protection suggested two species of alpha 1 (I) mRNA, one of which was not collinear with fully spliced alpha 1 (I) mRNA. The noncollinear population was confined to the nuclear compartment of the cell, and contained the entire sequence of intron 26 and a G-->A transition in the first position of the intron donor site. The G-->A transition was also identified in the genomic DNA. The retained intron contained an in-frame stop codon and introduced an out-of-frame insertion within the collagen mRNA producing stop codons downstream of the insertion. These changes probably account for the failure of the mutant RNA to appear in the cytoplasm. Unlike other splice site mutations within collagen mRNA that resulted in exon skipping and a truncated but inframe RNA transcript, this mutation did not result in production of a defective collagen pro alpha 1 (I) chain. Instead, the mild nature of the disease in this case reflects failure to process the defective mRNA and thus the absence of a protein product from the mutant allele.

Related Genes
MeSH Terms
Adolescent Alleles Alternative Splicing Amino Acid Sequence Base Sequence Cell Line Collagen/biosynthesis,genetics Exons Female Fibroblasts/metabolism Humans Introns Molecular Sequence Data Mutation Oligodeoxyribonucleotides Osteogenesis Imperfecta/genetics Polymerase Chain Reaction RNA, Messenger/genetics,metabolism Skin/metabolism
Chemicals
Oligodeoxyribonucleotides RNA, Messenger Collagen
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Stover M L
Department of Pediatrics, University of Connecticut Health Center, Farmington 06030.
Primorac D
Liu S C
McKinstry M B
Rowe D W
References (52)
52 references, click to expand
  1. Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins.
    Biochemistry. 1971 Mar 16;10(6):988-94 PMID: 4323854
  2. Differential utilization of regulatory domains within the alpha 1(I) collagen promoter in osseous and fibroblastic cells.
    J Cell Biol. 1992 Jan;116(1):227-36 PMID: 1730746
  3. Cloning a cDNA for the pro-alpha 2 chain of human type I collagen.
    Proc Natl Acad Sci U S A. 1981 Jun;78(6):3516-20 PMID: 6267597
  4. Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen.
    Proc Natl Acad Sci U S A. 1982 Jun;79(12):3838-42 PMID: 6954526
  5. Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain.
    Nucleic Acids Res. 1982 Oct 11;10(19):5925-34 PMID: 6183642
  6. Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.
    J Clin Invest. 1983 Mar;71(3):689-97 PMID: 6826730
  7. Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta.
    Nature. 1983 Jul 7-13;304(5921):78-80 PMID: 6191221
  8. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.
    Anal Biochem. 1983 Jul 1;132(1):6-13 PMID: 6312838
  9. Cysteine in the triple-helical domain of one allelic product of the alpha 1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta.
    J Biol Chem. 1984 Sep 10;259(17):11129-38 PMID: 6469997
  10. Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation.
    J Biol Chem. 1984 Nov 10;259(21):12941-4 PMID: 6092353
  11. Presence of translatable mRNA for pro alpha 2(I) chains in fibroblasts from a patient with osteogenesis imperfecta whose type I collagen does not contain alpha 2(I) chains.
    Coll Relat Res. 1984 Oct;4(5):389-94 PMID: 6210173
  12. An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen.
    J Clin Invest. 1992 Feb;89(2):567-73 PMID: 1737847
  13. Cooperation of pre-mRNA sequence elements in splice site selection.
    Mol Cell Biol. 1992 May;12(5):2108-14 PMID: 1569943
  14. Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications.
    Nucleic Acids Res. 1992 Apr 11;20(7):1717-23 PMID: 1579465
  15. Osteogenesis imperfecta.
    Annu Rev Med. 1992;43:269-82 PMID: 1580589
  16. Simple, inexpensive preparation of T1/T2 ribonuclease suitable for use in RNase protection experiments.
    Biotechniques. 1992 Feb;12(2):231-2 PMID: 1377478
  17. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.
    J Clin Invest. 1992 Jul;90(1):219-28 PMID: 1634609
  18. Expression of mutant alpha (I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV.
    J Bone Miner Res. 1992 Jul;7(7):793-805 PMID: 1642148
  19. Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen.
    Am J Hum Genet. 1992 Sep;51(3):508-15 PMID: 1353940
  20. Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity.
    Biochem J. 1992 Nov 15;288 ( Pt 1):131-5 PMID: 1445258
  21. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta.
    Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1701-5 PMID: 8446583
  22. Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D.
    Biochemistry. 1984 Dec 4;23(25):6210-6 PMID: 6395893
  23. A beta zero-thalassemic beta-globin RNA that is labile in bone marrow cells is relatively stable in HeLa cells.
    Nucleic Acids Res. 1985 Apr 25;13(8):2855-67 PMID: 2582366
  24. Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA duplexes.
    Science. 1985 Dec 13;230(4731):1242-6 PMID: 4071043
  25. Analysis of cytoplasmic and nuclear messenger RNA in fibroblasts from patients with type I osteogenesis imperfecta.
    Methods Enzymol. 1987;145:223-35 PMID: 3474490
  26. Nonsense mutations in the human beta-globin gene affect mRNA metabolism.
    Proc Natl Acad Sci U S A. 1988 Apr;85(7):2056-60 PMID: 3353367
  27. Single base mutation in the pro alpha 2(I) collagen gene that causes efficient splicing of RNA from exon 27 to exon 29 and synthesis of a shortened but in-frame pro alpha 2(I) chain.
    Proc Natl Acad Sci U S A. 1988 Jul;85(14):5254-8 PMID: 2839839
  28. A 19-base pair deletion in the pro-alpha 2(I) gene of type I procollagen that causes in-frame RNA splicing from exon 10 to exon 12 in a proband with atypical osteogenesis imperfecta and in his asymptomatic mother.
    J Biol Chem. 1988 Aug 15;263(23):11407-13 PMID: 3403536
  29. A survey on intron and exon lengths.
    Nucleic Acids Res. 1988 Nov 11;16(21):9893-908 PMID: 3057449
  30. Detection of mutations in human type I collagen mRNA in osteogenesis imperfecta by indirect RNase protection.
    J Biol Chem. 1989 Jun 5;264(16):9632-7 PMID: 2542316
  31. A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta.
    J Biol Chem. 1989 Jul 5;264(19):10960-4 PMID: 2500431
  32. A base substitution in the exon of a collagen gene causes alternative splicing and generates a structurally abnormal polypeptide in a patient with Ehlers-Danlos syndrome type VII.
    EMBO J. 1989 Jun;8(6):1705-10 PMID: 2767050
  33. Temperature-dependent expression of a collagen splicing defect in the fibroblasts of a patient with Ehlers-Danlos syndrome type VII.
    J Biol Chem. 1989 Oct 5;264(28):16804-9 PMID: 2777808
  34. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing.
    Mol Cell Biol. 1989 Jul;9(7):2868-80 PMID: 2779551
  35. Exon definition may facilitate splice site selection in RNAs with multiple exons.
    Mol Cell Biol. 1990 Jan;10(1):84-94 PMID: 2136768
  36. Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I.
    J Clin Invest. 1990 Jan;85(1):282-90 PMID: 2295701
  37. An intron mutation in the human alpha 1(I) collagen gene alters the efficiency of pre-mRNA splicing and is associated with osteogenesis imperfecta type II.
    J Biol Chem. 1990 Feb 5;265(4):2262-8 PMID: 2298750
  38. Identical G+1 to A mutations in three different introns of the type III procollagen gene (COL3A1) produce different patterns of RNA splicing in three variants of Ehlers-Danlos syndrome. IV. An explanation for exon skipping some mutations and not others.
    J Biol Chem. 1990 Jul 15;265(20):12067-74 PMID: 2365710
  39. Structural and functional characterization of a splicing mutation in the pro-alpha 2(I) collagen gene of an Ehlers-Danlos type VII patient.
    J Biol Chem. 1990 Sep 15;265(26):16007-11 PMID: 2394758
  40. Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA.
    Mol Cell Biol. 1990 Oct;10(10):5215-25 PMID: 2398889
  41. Brittle bones--fragile molecules: disorders of collagen gene structure and expression.
    Trends Genet. 1990 Sep;6(9):293-300 PMID: 2238087
  42. Effect of 5' splice site mutations on splicing of the preceding intron.
    Mol Cell Biol. 1990 Dec;10(12):6299-305 PMID: 2247057
  43. Identification of nuclear proteins that specifically bind to RNAs containing 5' splice sites.
    Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):320-4 PMID: 1824871
  44. The effects of different cysteine for glycine substitutions within alpha 2(I) chains. Evidence of distinct structural domains within the type I collagen triple helix.
    J Biol Chem. 1991 Feb 5;266(4):2590-4 PMID: 1990009
  45. Mutations in collagen genes: causes of rare and some common diseases in humans.
    FASEB J. 1991 Apr;5(7):2052-60 PMID: 2010058
  46. A type I collagen with substitution of a cysteine for glycine-748 in the alpha 1(I) chain copolymerizes with normal type I collagen and can generate fractallike structures.
    Biochemistry. 1991 May 21;30(20):5081-8 PMID: 2036375
  47. Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta.
    Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5423-7 PMID: 2052622
  48. Osteogenesis imperfecta: translation of mutation to phenotype.
    J Med Genet. 1991 Jul;28(7):433-42 PMID: 1895312
  49. Mutation of the AAUAAA polyadenylation signal depresses in vitro splicing of proximal but not distal introns.
    Genes Dev. 1991 Nov;5(11):2086-95 PMID: 1657710
  50. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.
    J Clin Invest. 1991 Dec;88(6):1880-5 PMID: 1721624
  51. The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria.
    Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):281-5 PMID: 1729699
  52. The estimation of two collagens from human dermis by interrupted gel electrophoresis.
    Biochem Biophys Res Commun. 1976 Oct 18;72(4):1472-80 PMID: 793589
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1993-10-00
Pages
1994-2002
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC288367
Subset
IM
Grants
NIAMS NIH HHS · AR-30426 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com